[HTML][HTML] Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies
Newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are continuously posing high global public health concerns and panic resulting in waves of …
are continuously posing high global public health concerns and panic resulting in waves of …
Recent developments in the immunopathology of COVID‐19
There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …
[HTML][HTML] Omicron (B. 1.1. 529) variant of SARS‐CoV‐2: concerns, challenges, and recent updates
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
Clinical characteristics of COVID-19 patients infected by the Omicron variant of SARS-CoV-2
J Zhang, N Chen, D Zhao, J Zhang, Z Hu… - Frontiers in medicine, 2022 - frontiersin.org
Background Currently, as the omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
Sensitivity to vaccines, therapeutic antibodies, and viral entry inhibitors and advances to counter the SARS-CoV-2 Omicron variant
H Zhou, M Møhlenberg, JC Thakor… - Clinical microbiology …, 2022 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) keeps evolving and
mutating into newer variants over time, which gain higher transmissibility, disease severity …
mutating into newer variants over time, which gain higher transmissibility, disease severity …
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2
L Zhang, KK Narayanan, L Cooper… - EMBO Molecular …, 2022 - embopress.org
Monoclonal antibodies targeting the SARS‐CoV‐2 spike (S) neutralize infection and are
efficacious for the treatment of COVID‐19. However, SARS‐CoV‐2 variants, notably …
efficacious for the treatment of COVID‐19. However, SARS‐CoV‐2 variants, notably …
Molnupiravir: A versatile prodrug against SARS-CoV-2 variants
The nucleoside analog β-DN 4-hydroxycytidine is the active metabolite of the prodrug
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …
molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the …
Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
Abstract SARS-CoV-2, although not being a circulatory virus, spread from the respiratory
tract resulting in multiorgan failures and thrombotic complications, the hallmarks of fatal …
tract resulting in multiorgan failures and thrombotic complications, the hallmarks of fatal …
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
COVID-19 is a highly transmissible disease caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in> 6.2 …
coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in> 6.2 …
The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection
Y Lin, Q Sun, B Zhang, W Zhao, C Shen - Frontiers in Cell and …, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) was a global endemic that continues to cause a
large number of severe illnesses and fatalities. There is increasing evidence that non-coding …
large number of severe illnesses and fatalities. There is increasing evidence that non-coding …